Eris Lifesciences Limited has informed the Exchange regarding 'closure of the transaction related to acquisition of Probiotics business of Velbiom Probiotics Private Limited'.
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Eris Lifesciences has completed the acquisition of the Probiotics business of Velbiom Probiotics Private Limited. This is an update to the company's earlier intimation dated March 20, 2026, confirming that the transaction has now achieved closure. The company has informed both BSE and NSE about the completion. No financial details, deal value, or revenue contribution of the acquired business have been disclosed in this update.
The acquisition is now officially complete, which means the Probiotics business is now part of Eris Lifesciences' portfolio. Shareholders should expect any future revenue or margin contribution from this business to start reflecting in the company's financials, though the size and terms of the deal were not detailed in this closure notice.